Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
D000941:Antigens; D000961:Antilymphocyte Serum; D001943:Breast Neoplasms / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D004407:Dysgerminoma / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D007680:Kidney Neoplasms / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008545:Melanoma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000276:immunology; D012509:Sarcoma / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D000941:Antigens; D000961:Antilymphocyte Serum